How Will Advanced APMs Affect Urology Physician Reimbursement in 2026?
Every urology practice that bills Medicare is, whether it realizes it or not, already positioned somewhere inside a much bigger shift: away from paying strictly for volume and toward paying, at least in part, for value. Advanced Alternative Payment Models are the sharpest edge of that shift, and 2026 is the first year Medicare is actually paying two different rates depending on where a practice sits relative to that model.
Could Advanced APM participation change how urologists are reimbursed — and what should a practice actually do to prepare?
The honest answer depends on program-specific details that vary by entity, but the direction of the policy is now clear enough that it's worth understanding before it shows up as a surprise on a remittance advice.
Quick Answer
Starting January 1, 2026, Medicare uses two separate physician fee schedule conversion factors for the first time: a higher one for clinicians who qualify as Advanced APM participants (QPs), and a lower one for everyone else. Whether Advanced APM participation makes sense for a given urology practice depends on program eligibility, patient volume, and Medicare payment thresholds — not a blanket recommendation.
What Are Advanced Alternative Payment Models (Advanced APMs)?
Advanced APMs are a track within Medicare's Quality Payment Program, created under MACRA, that ask participating clinicians to take on meaningfully more financial accountability for cost and quality than traditional fee-for-service billing requires. In exchange for that added risk, Advanced APM entities that meet specific participation thresholds can be designated Qualifying Participants, or QPs — a status that comes with a higher Medicare Physician Fee Schedule conversion factor and an exemption from MIPS reporting.
In Simple Terms
Fee-for-service pays for what gets done. Advanced APMs also weigh how well it was done and at what cost, and ask the practice to share in some of that financial risk. Practices that clear the participation bar get treated differently by Medicare's payment formula than practices that don't.
How Do Advanced APMs Differ From Traditional Medicare Payment?
Traditional Fee-for-Service | Advanced APM Approach |
Payment tied mainly to services delivered | Payment incorporates performance and accountability |
Volume-focused structure | Greater emphasis on value and outcomes |
Limited downside financial risk | May involve meaningful financial risk requirements |
Individual service reimbursement | Broader, entity-level performance measurement |
Single conversion factor applies | Separate, higher conversion factor for QPs starting in 2026 |
Program-specific requirements vary. This table describes the general shape of the difference, not a substitute for reviewing a specific model's terms.
Why Advanced APMs Matter to Urology Physicians in 2026
Urology is not typically thought of as a value-based-care specialty in the way primary care or oncology often are, and the number of Advanced APM options open to urologists specifically remains limited. That doesn't make the policy irrelevant. Medicare's broader reimbursement direction — more performance accountability, more reporting expectations, and now a literal split in the conversion factor — affects how every practice's Medicare revenue is calculated, whether or not that practice is currently in an Advanced APM. A practice that understands the mechanics now is better positioned to evaluate participation opportunities as they become available, rather than reacting after a payment adjustment already happened.
How Could Advanced APM Participation Affect Urology Physician Reimbursement?
Potential Financial Opportunities
Qualifying Participants receive a higher Medicare Physician Fee Schedule conversion factor than non-QPs, are exempt from separate MIPS reporting and its associated payment adjustments, and — depending on the specific Advanced APM — may have access to performance-based incentive payments tied to cost and quality outcomes. Some participation pathways are also designed to reduce certain administrative reporting burdens compared with standard MIPS.
Potential Financial Risks
Advanced APM participation generally requires accepting more than nominal financial risk for cost outcomes, which means a practice can also come out behind if performance or cost targets aren't met. Meeting Qualifying Participant thresholds requires real infrastructure: accurate data capture, reliable reporting, and documentation that actually supports what's being reported. A practice without that infrastructure may find participation adds administrative complexity without a clear financial upside.
2026 Conversion Factor Snapshot
CMS finalized two separate 2026 Medicare Physician Fee Schedule conversion factors for the first time: approximately $33.5675 for clinicians designated as Qualifying APM Participants, compared with approximately $33.4009 for non-QPs. That's roughly a half-percent difference built directly into the payment formula, on top of whatever additional incentive or risk exists within a specific Advanced APM itself.
Figures reflect CMS's 2026 final rule and should be verified against current CMS guidance, since methodology and updates can change.
Advanced APMs vs. MIPS: What Is the Difference for Urologists?
To become a Qualifying Participant, CMS generally looks at whether a clinician meets threshold levels of Medicare Part B payments or patient volume through an Advanced APM entity; clinicians who fall short of the full threshold may still qualify as Partial QPs under lower thresholds. Eligibility and thresholds should always be confirmed against current CMS guidance, since they are assessed and can be adjusted annually.
The Revenue Cycle Impact: What Urology Practices Should Prepare For
Whether or not a practice pursues Advanced APM participation, the broader shift toward performance-linked reimbursement raises the stakes on revenue cycle fundamentals that matter regardless of payment model: accurate coding, complete clinical documentation, eligibility verification, clean charge capture, clean claim submission, denial prevention, payment reconciliation, ongoing A/R monitoring, and genuine visibility into performance data.
A practice with weak fundamentals in fee-for-service will not suddenly perform well under a model that also measures cost and quality — those weaknesses tend to show up more visibly, not less.
Is Your Urology Practice Ready?
☐ Do we understand which value-based programs affect our physicians?
☐ Are our documentation workflows aligned with reporting requirements?
☐ Can we accurately track reimbursement performance over time?
☐ Do we regularly analyze denial trends rather than just clearing them?
☐ Is our coding process reviewed or audited on a regular basis?
☐ Can our billing data actually identify potential revenue leakage?
If multiple answers are “no” or “not sure,” the practice may benefit from a closer look at its revenue cycle before payment model changes force the issue.
Request a Revenue Cycle Assessment A structured review can help identify where documentation, coding, and claims workflows may be falling short of what performance-linked reimbursement rewards. |
Common Mistakes Urology Practices Should Avoid
1. Assuming value-based reimbursement works the same as fee-for-service. It doesn't — cost and quality performance carry real financial weight, not just volume.
2. Ignoring documentation quality. Reporting requirements depend on documentation that actually supports what's submitted.
3. Treating billing and clinical performance as separate. Under performance-linked models, they're directly connected.
4. Failing to monitor reimbursement data. Without visibility, a practice can't tell whether it's gaining or losing ground.
5. Waiting until payment changes take effect before evaluating workflows. Readiness takes longer to build than a single billing cycle.
6. Not reviewing denials and underpayments systematically. Isolated fixes rarely address the underlying pattern.
7. Relying on outdated assumptions about Medicare participation status. QP status is assessed and can change; last year's assumption may not hold.
How Medical Billing Support Can Help Urology Practices Prepare
Professional revenue cycle support can help a practice build the operational readiness that performance-linked reimbursement rewards: billing workflow analysis, claims monitoring, coding coordination, denial trend analysis, accounts receivable follow-up, accurate payment posting, underpayment identification, and clearer revenue reporting.
Sirius Solutions Global works with healthcare practices on exactly these fundamentals — not as a substitute for a practice's own clinical and financial decisions, but as operational support underneath them. Learn more about our medical billing and RCM services.
Frequently Asked Questions
Q: Can urologists participate in Advanced APMs?
A: Some urologists can, depending on which Advanced APM entities and models they have access to; the number of models open to urology specifically is more limited than for some other specialties, so eligibility should be confirmed directly.
Q: How do Advanced APMs affect Medicare reimbursement?
A: Starting in 2026, Qualifying Participants receive a higher Medicare Physician Fee Schedule conversion factor than non-QPs, plus potential model-specific incentive payments, in exchange for taking on more financial accountability for cost and quality.
Q: What is the difference between MIPS and Advanced APM participation?
A: MIPS scores individual or group performance against a points threshold with adjustments applied accordingly; Advanced APM participation happens at the entity level and can exempt Qualifying Participants from MIPS reporting entirely.
Q: Do Advanced APMs guarantee higher reimbursement?
A: No. Financial outcomes depend on the specific model's terms, whether QP thresholds are met, and how the entity performs against cost and quality measures — results vary by practice and are never guaranteed.
Q: How should a urology practice prepare for value-based reimbursement?
A: By strengthening core revenue cycle fundamentals now — documentation, coding accuracy, denial analysis, and performance visibility — rather than waiting until a specific payment model directly affects the practice.
Key Takeaways
• 2026 marks the first year Medicare uses separate conversion factors for QPs and non-QPs.
• Advanced APM participation involves real financial risk, not just upside.
• Eligibility and thresholds are determined by CMS and should be verified directly.
• Revenue cycle fundamentals matter under every payment model, not just fee-for-service.
• Readiness is built over time, not assembled after a policy change takes effect.
Advanced APMs are one piece of a much larger move toward value-based Medicare reimbursement, and urology practices don't need to be enrolled in one today to be affected by the direction it represents. The practices in the strongest position tend to be the ones that treat documentation, coding accuracy, denial analysis, and revenue visibility as ongoing work — not a project to start once a new payment model arrives.
Sirius Solutions Global supports healthcare practices with exactly that kind of revenue cycle groundwork. If your practice wants a clearer picture of where it stands, request a revenue cycle assessment and start the conversation.
Disclaimer: This article is provided for general educational and informational purposes only and does not constitute legal, financial, regulatory, coding, or compliance advice. Medicare policies, Quality Payment Program requirements, Advanced APM eligibility, and reimbursement rates are subject to change and should be verified against current official CMS guidance. Individual practice financial outcomes will vary and are not guaranteed. Healthcare organizations should consult qualified legal, compliance, or reimbursement professionals when making participation or billing decisions.
